Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells.
about
Aberrant expression of ZNF268 alters the growth and migration of ovarian cancer cellsSHARPIN is an endogenous inhibitor of β1-integrin activationThe PTEN tumor suppressor gene and its role in lymphoma pathogenesisPhosphatase and Tensin Homologue: Novel Regulation by Developmental SignalingFocus on PTEN RegulationPTEN modulators: a patent reviewLinear ubiquitination signals in adaptive immune responsesBeta 1-integrin-c-Met cooperation reveals an inside-in survival signalling on autophagy-related endomembranes.Therapeutic targeting of cancers with loss of PTEN function.Microvesicles Contribute to the Bystander Effect of DNA Damage.Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.PTEN Tumor Suppressor Network in PI3K-Akt Pathway ControlContactin-1 reduces E-cadherin expression via activating AKT in lung cancer.Regulation of the tumor suppressor PTEN through exosomes: a diagnostic potential for prostate cancer.Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses.Elevation of SIPL1 (SHARPIN) Increases Breast Cancer RiskMutually Exclusive Roles of SHARPIN in Integrin Inactivation and NF-κB Signaling.SHARPIN is a key regulator of immune and inflammatory responsesThe pathogenesis of chronic eosinophilic esophagitis in SHARPIN-deficient micePTEN at a glance.Sharpin promotes hepatocellular carcinoma progression via transactivation of Versican expression.Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways.The emerging role of linear ubiquitination in cell signaling.PTEN function: the long and the short of it.Common reduction of the Raf kinase inhibitory protein in clear cell renal cell carcinoma.The Sharpin interactome reveals a role for Sharpin in lamellipodium formation via the Arp2/3 complex.SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP, DU145 and PC-3 cells via NF-κB/ERK/Akt signaling pathway.Activation of nuclear factor κB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancer.SHARPIN regulates collagen architecture and ductal outgrowth in the developing mouse mammary gland.α-Mannosidase 2C1 attenuates PTEN function in prostate cancer cells.Signatures derived from increase in SHARPIN gene copy number are associated with poor prognosis in patients with breast cancer.Activation by ACA induces pluripotency in human blood progenitor cells.SHARPIN stabilizes estrogen receptor α and promotes breast cancer cell proliferation.SHARPIN-mediated regulation of protein arginine methyltransferase 5 controls melanoma growth.Elevation of SHARPIN Protein Levels in Prostate Adenocarcinomas Promotes Metastasis and Impairs Patient Survivals.Etoposide-induced DNA damage affects multiple cellular pathways in addition to DNA damage response.Biphasic Alteration of Butyrylcholinesterase (BChE) During Prostate Cancer Development.
P2860
Q24317600-43B3D468-8DA0-4DD3-A029-09D3D0BC5A2EQ24338618-19541117-624F-4BBF-B19D-81FB98656C04Q26776527-8E6D2F4A-17BA-4C03-9B6E-E63BEE38A76CQ26784590-E5A461A6-AFCF-42F4-B087-36C41B38FEFFQ26797287-2998E5E4-445F-4FD2-8E98-5727BFF7902DQ26995513-99A6E5F5-906B-40D0-9EEA-DA22AD7C8F94Q27027872-C1F854B0-66DB-4ACA-B2F6-EE424B66A6BDQ27342529-BFD625F4-EDFC-4D42-9E60-16D21E95ECD1Q27852764-F6295E0B-3F86-4806-9C22-8297C2B479BAQ33624594-C677D004-1188-454B-8656-9A37B2EAB109Q34173253-62871DCA-8041-4C33-B038-535954C44CEAQ34202681-6655A084-876C-4590-B9F8-020F7568EC66Q34750104-D817DDF8-D9D8-490D-BD96-8848EA3DAE90Q34921868-E27EFADF-922C-463B-825C-4EBAEF052D4AQ35105277-99E4CB44-8C30-4EBB-A048-E96EDB8B1E18Q35625533-F23D43E3-C7BD-4E76-B059-182B36C51A65Q35850779-2D914FA9-AB86-4EA6-ABC4-DCAF58431FE6Q36110258-A9BAB47B-999C-4424-B8A9-41EBC2CF2469Q36373435-791F2742-DBAE-4DCB-B573-BEBCD948C50BQ36452913-81B9153C-92F3-44D0-B0A2-7384DD8B931AQ37525791-AC07BCBB-4946-48F3-A428-F877B05C9DABQ37837732-17DDFA07-EB62-4486-B5FC-089F436C13ECQ37989135-CC3B53F6-C1B1-4BFA-89AF-5A1304C7E2A9Q38198345-2D97ADA3-905A-4373-9B62-05A1C5F85C43Q38303772-183BBDFD-7096-47FD-B03C-F078674A75F1Q38642362-F1DE7632-7EFF-43D1-A299-A46B4EDB6ABCQ38924340-1A6F6C8B-EB80-4D0C-BC1C-3F74DEE5F301Q38985281-EEAF721F-DB4E-4F03-900E-B74D93EA078AQ39100604-DF78973E-1DCE-4142-AA15-FF8A8CE814FBQ39545547-73E92F94-A33B-4368-B8D8-FB3EA1B77F4FQ41600805-A8DB8EBF-0E3A-4F1D-AAA3-BA2B39D7CF94Q43529216-2B8307E5-8411-422D-A93B-E93B3A9646C5Q43767523-B944867F-6AF4-4293-AB5C-0BD991B40846Q46718948-34874C4D-DAB8-42BA-BAEF-59A0B22866EFQ51125940-A60E8117-A145-40C2-8C72-B4876ADAF6BAQ54969815-B0B5217D-6480-4F46-9F66-445367AB4F24Q55518954-B97DBA10-214F-45E8-B4CA-B7CDEE187E94
P2860
Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Shank-interacting protein-like ...... hibition in human tumor cells.
@ast
Shank-interacting protein-like ...... hibition in human tumor cells.
@en
type
label
Shank-interacting protein-like ...... hibition in human tumor cells.
@ast
Shank-interacting protein-like ...... hibition in human tumor cells.
@en
prefLabel
Shank-interacting protein-like ...... hibition in human tumor cells.
@ast
Shank-interacting protein-like ...... hibition in human tumor cells.
@en
P2093
P2860
P356
P1476
Shank-interacting protein-like ...... nhibition in human tumor cells
@en
P2093
Alistair Ingram
P2860
P304
P356
10.1172/JCI40778
P407
P577
2010-05-10T00:00:00Z